Seoul, South Korea

Seulgi Yoon

This inventor holds 1 USPTO granted patent. Top assignee: Nexel Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seulgi Yoon. Retrieved from https://idiyas.com/inventor/seulgi-yoon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seulgi Yoon and Cardiac Safety Testing

Introduction

Seulgi Yoon is an inventor associated with Nexel Co., Ltd. in Seoul, South Korea. Her patent work focuses on evaluating the cardiac safety of drugs using cardiomyocytes derived from human stem cells.

Latest Patents

Yoon is named on 1 patent, titled “Methods for Evaluating Cardiac Safety of Drug Using Cardiomyocytes Derived from Human Stem Cells.” The method describes differentiating human stem cells into cardiomyocytes, preparing fibronectin-coated wells on a microelectrode array (MEA) plate, and measuring changes in beat rate, spike amplitude, and field potential duration after a drug is added. These measurements can help assess a drug’s potential cardiac effects.

Career Highlights

Yoon’s listed invention applies human stem cell-derived cardiomyocytes and MEA measurements to drug safety evaluation. Her work is associated with Nexel Co., Ltd.

Collaborations

Yoon’s listed coworkers include Donghun Woo and Jieun An.

Conclusion

Seulgi Yoon’s patent describes a cell-based approach to evaluating drug-related cardiac safety, using measurable electrical activity in human stem cell-derived cardiomyocytes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…